Clinical Trial Update: Audit of the Effect of Changing From IV to SC Administration of ESA's in Haemodialysis Patients

View source ↗

Summary

This completed clinical trial audited the effects of switching erythropoiesis-stimulating agents from intravenous to subcutaneous administration in haemodialysi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Snippet

Sponsor: Sir Charles Gairdner Hospital | Conditions: Kidney Failure, Chronic, Anemia | Status: COMPLETED